Showing results (1031-1040 of 1,289) with videos related to

Sort By:
Pageof 129
Clinical Genetics|October 7, 2005
An analysis of PAX1 in the development of vertebral malformationsP F Giampietro, C L Raggio, C E Reynolds, et al.
Pediatric Diabetes|January 22, 2019
Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!)Sophie Guilmin-Crépon, Jean-Claude Carel, Julien Schroedt, et al.
Archives of Cardiovascular Diseases|January 23, 2026
Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathyVincent Algalarrondo, Olivier Lairez, Marion Narbeburu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2024
Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacyMichael H Zaleski, Serena Omo-Lamai, Jia Nong, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 16, 2014
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic strokeH Bart van der Worp, Malcolm R Macleod, Philip M W Bath, et al.
Annals of Emergency Medicine|March 6, 2018
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled TrialNicolas Javaud, Olivier Fain, Isabelle Durand-Zaleski, et al.
Circulation. Cardiovascular Interventions|August 23, 2021
Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI TrialPierre Denormandie, Tabassome Simon, Guillaume Cayla, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
JAMA|February 9, 2021
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical TrialGregory Ducrocq, Jose R Gonzalez-Juanatey, Etienne Puymirat, et al.
Annals of Surgery|December 24, 2016
Medical and Economic Evaluation of FOREseal Bioabsorbable Reinforcement Sleeves Compared With Current Standard of Care for Reducing Air Leakage Duration After Lung Resection for Malignancy: A Randomized TrialMarco Alifano, Christophe Jayle, François Bertin, et al.
Pageof 129